Looks like that acquisition of rival Par Pharmaceutical is working out for Endo International Plc – Ordinary Shares (NASDAQ:ENDP), as earnings were helped big-time by the boost in pharmaceutical sales. Overall, Endo’s revenues …
'Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
For the second quarter of 2014, Endo International PLC (NASDAQ:ENDP) reported net income of $21 million, down from …
Shares of Collegium Pharmaceutical Inc. COLL, -4.05% shot up 10% in active morning trade Friday, amid expectations that the pain treatment maker will get a big boost from rival Endo International PLC's ENDP ... That sent Endo's stock
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. …
Shares of Endo International PLC closed the previous trading session at 8.14 up +0.52 6.82% with 13,400,643 shares …
On June 8, the FDA asked Endo International Plc (ENDP) to voluntarily withdraw its opioid agonist ... its shares fell only 5 percent on Friday. However, Depomed's stock price is down nearly 45 percent through June 9. Insys Therapetics Inc. …
Net sales of Opana ER in 2016 declined to $158.94 million from $175.77 million in 2015. ENDP closed Thursday's trading at $13.78, up 11.13%. In after-hours, the stock fell 13.50% to $11.92. The FDA has removed the clinical hold on Inovio …
SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating reasons underlying Endo International plc’s (NASDAQ: ENDP) dramatic stock drop and whether it violated …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …